Get the app!
Back to Trades
Filing Date
Mar 2, 2026
1 transactions

Trade Summary

On Feb 27, 2026 through Mar 1, 2026, 325 CAPITAL LLC, Insider, reported $0 of TRANSACT TECHNOLOGIES INC (TACT) across 1 transactions. The filing covers Common Stock and reflects balanced net activity of $0. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.

Company Information

Ticker Symbol
TACT
CIK
0001017303

Insider Information

Role
Insider
Location
NEW YORK, NY

Filing Details

Filing Date
Mar 2, 2026
Transaction Date
Feb 27, 2026
Accession Number
0001214659-26-002707
Form Type
4

Non-Derivative Transactions

DateSecuritySharesPriceTypeValue
Feb 27, 2026Common Stock2,850Exercise
Feb 28, 2026Common Stock1,675Exercise
Mar 1, 2026Common Stock1,600Exercise

Derivative Transactions

DateSecuritySharesExercise PriceTypeValue
Feb 27, 2026TACT derivative2,850Exercise
Feb 28, 2026TACT derivative1,675Exercise
Mar 1, 2026TACT derivative1,600Exercise

Want live alerts when 325 CAPITAL LLC trades again?

Download Insider Trades to track TACT, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.

Footnotes

  1. (F1)Restricted Stock Units issued on February 27, 2025 pursuant to the Company's 2014 Equity Incentive Plan, as Amended and Restated, vesting 25% annually commencing on the first anniversary date of the grant and converting to common stock on a one-for-one basis.
  2. (F2)Restricted Stock Units issued on February 29, 2024 pursuant to the Company's 2014 Equity Incentive Plan, as Amended and Restated, vesting 25% annually commencing on the first anniversary date of the grant, that have converted to common stock on a one-for-one basis.
  3. (F3)Restricted Stock Units issued on March 1, 2023 pursuant to the Company's 2014 Equity Incentive Plan, as Amended and Restated, vesting 25% annually commencing on the first anniversary date of the grant, that have converted to common stock on a one-for-one basis.
  4. (F4)This Report is filed jointly by 325 Capital LLC, a Delaware limited liability company ("325"), 325 Capital Master Fund LP, a Cayman Islands exempted limited partnership ("325 Master Fund"), 325 Capital GP, LLC, a Delaware limited liability company registered as a foreign partnership in the Cayman Islands ("325 Capital GP"), Michael D. Braner, a citizen of the United States of America, Daniel M. Friedberg, a citizen of the United States of America, and Anil K. Shrivastava, a citizen of the United States of America (collectively, the "Reporting Persons"), each of whom may be deemed to have a pecuniary interest in the securities reported on this Form 4.
  5. (F5)These securities are owned directly by Daniel M. Friedberg, a Managing Member of 325 who serves on the board of directors of TransAct Technologies Incorporated (the "Company"). 325 is entitled to receive all of the economic interest in securities granted to Mr. Friedberg in respect of Mr. Friedberg's service on the board of directors, and may therefore be deemed to beneficially own these securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended. 325 Capital GP is the general partner of 325 Master Fund, 325 is the investment manager to 325 Master Fund, and each of Messrs. Braner, Friedberg and Shrivastava are Managing Members of 325. As a result, all of the Reporting Persons may be deemed to beneficially own the securities owned directly by Mr. Friedberg. The other Reporting Persons may also be deemed "directors by deputization" of the Company.
  6. (F6)Each of the Reporting Persons disclaims any beneficial ownership of any of these securities, except to the extent of any pecuniary interest therein.
  7. (F7)These securities are owned directly by 325 Master Fund. As a result of the relationships described in Footnote (5) above, all of the Reporting Persons may be deemed to beneficially own the securities owned directly by 325 Master Fund.

SEC Filing

View on SEC Daily

View the complete filing document on SEC Daily.